Infixion Bioscience

Infixion Bioscience is a preclinical drug discovery company focused on developing gene-targeted therapies for the rare genetic disorder Neurofibromatosis Type 1 (NF1). Infixion Bioscience's mission is to discover and develop treatments that fundamentally improve the lives of patients with NF1.